Short answer
PROCEPT BioRobotics Corp (PRCT) filed its Q1 2026 10-Q quarterly report on Apr 30, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $83M (up 20.2% year over year) with net income of −$32M.
Q1 2026 key financials · XBRL
- Revenue
- $83M
- +20.2% YoY
- Net income
- −$32M
- −27.9% YoY
- Operating margin
- -39.2%
- Gross margin
- 64.9%
- EPS (diluted)
- −$0.56
- −24.4% YoY
Source: XBRL data from the PROCEPT BioRobotics Corp (PRCT) Q1 2026 10-Q on SEC EDGAR. USD.
PROCEPT BioRobotics Corp Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $83.1M, up 20% YoY from $69.2M
- Gross margin 65% vs 64% YoY; net loss $31.6M vs $24.7M
- Best line service revenue $6.5M, up 57%; handpieces and consumables $49.4M
- Operating cash use $38.1M vs $17.0M; cash and equivalents $245.6M
- Outlook: cash and anticipated revenue sufficient through at least next twelve months; expenses expected to increase
Risk Factors
- No material changes to previously disclosed risk factors during quarter ended March 31, 2026
- Carried-forward broad business risk: unknown or currently immaterial risks could materially adversely affect results
- Regulatory compliance risk: CFO Rule 10b5-1 plan permits sales of up to 59,127 shares through June 17, 2027
- Market performance risk: historical financial performance may not reliably indicate future results
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other PROCEPT BioRobotics Corp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.